Axsome Therapeutics
AXSM
AXSM
163 hedge funds and large institutions have $1.34B invested in Axsome Therapeutics in 2020 Q1 according to their latest regulatory filings, with 45 funds opening new positions, 64 increasing their positions, 40 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
4% less funds holding
Funds holding: 169 → 163 (-6)
33% less funds holding in top 10
Funds holding in top 10: 12 → 8 (-4)
42% less capital invested
Capital invested by funds: $2.31B → $1.34B (-$965M)
Holders
163
Holding in Top 10
8
Calls
$107M
Puts
$73.4M
Top Buyers
| 1 | +$90.4M | |
| 2 | +$40.3M | |
| 3 | +$30.5M | |
| 4 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$18.3M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$18.1M |
Top Sellers
| 1 | -$50.7M | |
| 2 | -$45.7M | |
| 3 | -$42.2M | |
| 4 |
Millennium Management
New York
|
-$20.7M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$19.6M |